Humana (NYSE:HUM) Issues FY 2024 Earnings Guidance

Humana (NYSE:HUM) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 16.000-16.000 for the period, compared to the consensus estimate of 16.360. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on HUM. Barclays lowered their price target on Humana from $356.00 to $310.00 and set an equal weight rating on the stock in a research note on Tuesday, April 2nd. UBS Group lowered their price objective on Humana from $334.00 to $326.00 and set a neutral rating on the stock in a research note on Thursday, April 25th. Baird R W upgraded Humana to a hold rating in a research note on Thursday, May 30th. Jefferies Financial Group lowered their price objective on Humana from $411.00 to $381.00 and set a buy rating on the stock in a research note on Monday, April 22nd. Finally, TD Cowen lowered their price objective on Humana from $427.00 to $396.00 and set a buy rating on the stock in a research note on Tuesday, April 2nd. Thirteen investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of Hold and a consensus price target of $423.63.

Humana Price Performance

Shares of NYSE:HUM opened at $355.48 on Monday. The firm has a market cap of $42.84 billion, a PE ratio of 22.13, a price-to-earnings-growth ratio of 2.09 and a beta of 0.53. The firm’s fifty day moving average is $340.05 and its 200-day moving average is $354.76. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. Humana has a 52 week low of $298.61 and a 52 week high of $530.54.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. Humana’s revenue was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $9.38 earnings per share. Sell-side analysts predict that Humana will post 16.07 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.00%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.